Sentence examples for immunologic presentation from inspiring English sources

Systemic lupus erythematosus (SLE) has a heterogeneous clinical and immunologic presentation, with the commonality of B cell hyperactivity across the patient population.

After the translation process, the produced protein can enter in the class I pathway of immunologic presentation process for activation of CD8+ T cells or participate of cross-priming process for CD4+ T cells [ 27].

Therefore the reasons why HTLV-1 infection increases susceptibility to infection and severity of tuberculosis are not understood.The aim of this study was to evaluate how HTLV-1 may influence the clinical, bacteriologic and immunologic presentation of tuberculosis.

These data support the idea that septic patients are a heterogeneous population at different stages of disease and with differing immunologic status upon presentation to the ICU, but develop progressively increasing levels of immune exhaustion with protracted sepsis.

We systematically review according to drug-targeting pathway the cutaneous AE profiles of these drugs, and offer insight when possible into whether pharmacologic target versus immunologic modulation primarily underlie presentation.

To ensure the functionality and optimal presentation of immunologic epitopes, we generated two group-M consensus env genes that contain variable regions either from a wild-type B/C recombinant virus isolate (CON6) or minimal consensus elements (CON-S) in the V1, V2, V4, and V5 regions.

Considering the substantial differences in the immunologic mechanism and clinical presentation of non-IgE-mediated CMA, we believed of importance to explore the hypoallergenicity of this formula also in these patients.

Considering substantial differences in the immunologic mechanism and clinical presentation of non-IgE-mediated CMA it's important to investigate the hypoallergenicity of these formulas also in these patients.

DCs also possess unique immunologic characteristics (e.g. cross-presentation, linking innate and adaptive processes) that can be exploited in the development of additional biologic response therapies.

As a basic immunotherapy, DC vaccination is critical for initiating and boosting anti-GBM immunity; it has obvious complementarity with traditional treatments in promoting cross-presentation of antigens and long term immunologic memory, and it can prevent the recurrence and metastases of GBM [ 10].

When a T cell encounters bacterial products, either directly or via presentation by a special antigen-presenting cell, it is sensitized to recognize the material as foreign, and, once sensitized, it possesses an immunologic memory.